register

Marketing & Strategy

Consumer watchdog to impose hefty penalties on companies and social media influencers

Health Industry Hub | January 24, 2024 |

Marketing & Strategy: The Australian Competition and Consumer Commission (ACCC) conducted an extensive internet ‘sweep’ targeting influencer accounts across major platforms including Instagram, TikTok, Snapchat, YouTube, Facebook, and Twitch.

Focusing on seven sectors, including healthcare, the ACCC invited consumers, businesses, and industry participants to report instances of misleading conduct by influencers. A staggering 150 tip-offs were received prior to the sweep, primarily related to influencers failing to disclose commercial relationships in their posts.

Under the Australian Consumer Law (ACL), embedded within the Australian Competition and Consumer Act 2010, businesses, including social media influencers, are prohibited from misleading or deceiving consumers.

The ACCC identified various forms of misleading conduct in influencer marketing, such as:

  • Non-disclosure of brand relationships in social media posts.
  • Vague or confusing disclosure of brand relationships using terms like ‘sp,’ ‘spon,’ ‘sponcon,’ ‘collab,’ ‘creativepartner,’ ‘ambassador,’ and similar abbreviations.
  • False or inaccurate statements about brands, products, or services.
  • Other concerning conduct such as multi-level marketing schemes and subscription traps.

The report released last month showed the ACCC is concerned that “this conduct is becoming more pervasive over time as the influencer industry continues to grow”. 

To address these concerns, the ACCC proposes a multi-faceted approach involving education, compliance, and enforcement activities. The commission will also release updated guidance material for influencers, brands, and advertisers.

Warning of potential enforcement actions, the ACCC emphasised the importance of compliance with the law. Breaches of the ACL can result in significant penalties, and brands found guilty of misleading or deceiving consumers may suffer severe reputational damage. Social media influencers and brands are advised to ensure their advertising, marketing, and promotional activities align fully with legal standards, particularly in the examined sectors.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


Human Resources

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Health Industry Hub | May 20, 2024 |

People & Culture: Coinciding with International HR Day, Karen Newell, Senior HR Director for ANZ at Medtronic, joined Health Industry […]

More


News & Trends - MedTech & Diagnostics

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: An Australian-based medtech company announced promising results from the first-in-human study for its pulsed field ablation […]

More


News & Trends - MedTech & Diagnostics

Federal budget delivers 'mixed news' for radiologists

Federal budget delivers ‘mixed news’ for radiologists

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: The Royal College of Australian and New Zealand Radiologists (RANZCR) and the Interventional Radiology Society of […]

More


News & Trends - Pharmaceuticals

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

Health Industry Hub | May 20, 2024 |

Pharma News: The Senate Community Affairs References Committee has released its inquiry report into Equitable access to diagnosis and treatment […]

More


This content is copyright protected. Please subscribe to gain access.